A population-based congenital cytomegalovirus screening program in Ontario successfully screened 551,034 newborns; of those ...

Chemical structure of valganciclovir hydrochloride. VLGH is a FDA approved medication for the prevention of CMV disease in certain transplant recipients at high risk for developing CMV diseases ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Viracta ...

Further spending reductions were made through use of generic versions of the antifungal treatments Voriconazole, Valganciclovir and Caspofungin, and Prednisolone used to treat asthma patients.

a combination of the HDAC inhibitor nanatinostat and the antiviral valganciclovir. In August, the biotech posted phase 2 data for the combo, dubbed nana-val, in 21 patients with peripheral T-cell ...

(UC San Diego) Viracta Therapeutics announced the closure of a phase II trial of its combination therapy of the histone deacetylase inhibitor nanatinostat and the antiviral agent valganciclovir ...

After hours: 7:15:45 p.m. EST ...

Of the numerous risks associated with immunotherapy for the prevention of rejection, cost is perhaps the most universal. In the USA and some other countries, the costs of immunosuppression make ...

Herpes simplex virus type I (HSV-1) is a member of the α-herpesvirus subfamily and is capable of causing herpes simplex keratitis, herpes labialis, and herpes simplex encephalitis. HSV-1 is well known ...